Home > Press > RUSNANO Delegation visits Germany on April 8-9
Abstract:
The delegation of the Russian Corporation of Nanotechnologies (RUSNANO) at the head of the Director General, Anatoly Chubais, arrives to Germany on the 8th of April with a two-day visit.
Germany is one of the leading world economies and a strategic business partner of Russia. The purpose of this visit will be acquaintance with experience of establishing the German Institutes of Innovative Development and coming into contacts with the potential partners.
In the course of the visit Anatoly Chubais will have a number of working meetings with the representatives of the German political quarters, including the Minister of Economics K.-T. Guttenberg, Prime Minister of Saxony Land, Stanislav Tillich, and Deputy Prime-Minister of North Rhine-Westphalia Land, Michael Mertes.
Additionally, Anatoly Chubais is planning to participate in Conference "Nanotechnological Innovations in Contact Point between State and Business", which will take part in Berlin on the 8th of April. Within the conference framework it is also planned to sign the contract on establishing CJSC "NanoBrachyTech" between "Santis" Ltd., International Brachytherapy SA (Germany) and RUSNANO. CJSC "NanoBrachyTech" will become the leading company of the joint-venture on manufacturing the micro-sources, micro-spheres and accessories for performing brachytherapy treatments.
The final stage of the visit will include the meetings of the Corporation's delegation with the leaders of the German enterprises having their business activities at the territory of the research and technology park for innovative companies MST.Factory (Dortmund City).
####
About RUSNANO
The Russian Corporation of Nanotechnologies (RUSNANO) was established by the Federal Law in 2007. The corporation was charged with stimulating development, creating and strengthening infrastructure and realizing projects in nanotechnology and the nanoindustry. To accomplish this task, RUSNANO co-invests in nanotechnology projects that have high potential for commercial or social benefit. Early-stage investment by RUSNANO lowers the risk of its investment partners from the private sector.
RUSNANO participates in building nanotechnology infrastructure, which includes nanotechnology centers of excellence, business incubators and early stage investment funds. RUSNANO selects promising spheres for investment based on long-term forecast developed by leading Russian and world experts.
The corporation is open to international cooperation, which can be realized in many different forms, including joint ventures, interchange of data, infrastructural and educational projects. To assist the advancement of the Russian nanotechnology industry into global markets, RUSNANO organizes the annual Nanotechnology International Forum in Russia.
The corporation's budget is $5 billion. Its chief executive is Anatoly Chubais.
For more information, please click here
Contacts:
Anna Fradkova, press-secretary of the international press office
P.: +7 495 5424444 add.1424
M.: +7 985 7299860
Copyright © RUSNANO
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||